Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.

Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.

This year we’ve made a spectacular leap and **ranked 8th**, joining the league of TOP10 most promising start-ups in Switzerland in 2020.

Nanomechanical Sensors as a Tool for Bacteria Detection and Antibiotic Susceptibility Testing

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.